Edition:
India

Ovid Therapeutics Inc (OVID.OQ)

OVID.OQ on NASDAQ Stock Exchange Global Select Market

8.72USD
16 Jan 2018
Change (% chg)

-- (--)
Prev Close
$8.72
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,557
52-wk High
$15.70
52-wk Low
$5.28

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.380
Jun '17 0.00 -0.566
Mar '17 0.00 -1.392
FY 2016 Dec '16 0.00 -0.307
Sep '16 0.00 -0.235
Jun '16 0.00 -0.219
Mar '16 0.00 -0.150
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-18 4 -0.49 -0.43 -0.55 --
Quarter Ending Jun-18 4 -0.52 -0.47 -0.54 --
Year Ending Dec-18 4 -2.09 -1.93 -2.25 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -70.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ovid Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.95 -0.60 56 --
13 Week -13.70 -17.90 29 --
26 Week -- -- -- --
52 Week -- -- -- --
YTD -- -- -- --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 32.93%
# of Holders: 65
Total Shares Held: 8,102,363
3 Mo. Net Change: 631
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 6
# Reduced Positions: 1
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.